William D. Baird III Net Worth & Insider Trades
William D. Baird III - Chief Financial Officer, Amicus Therapeutics Inc
What is William D. Baird III's Net Worth?
The current estimated net worth of Amicus Therapeutics Inc's Chief Financial Officer, William D. Baird III, is estimated to be about $4.92M . William D. Baird III owns about 117,622 units of Amicus Therapeutics Inc common stock. In the last 6 years at Amicus Therapeutics Inc, William D. Baird III has sold an estimated value of $3.01M worth.
What is William D. Baird III's Past Insider Trading?
William D. Baird III's largest purchase order was 40,000 units , worth over $570.13K on October 16, 2017. William D. Baird III's largest sale order was 40,000 units , worth over $570.13K on October 16, 2017. In total, William D. Baird III has made about 26 transactions over 6 years of their time at Amicus Therapeutics Inc. William D. Baird III usually trades in January, with the busiest year in 2015 and 2014. The most recent transaction was a sale order of 10,000 units , worth over $122.27K on October 17, 2018.
William D. Baird III
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is William D. Baird III's' Mailing Address?
- Mailing address is C/o Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 MA
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics Inc's Past Insider Trades?
Amicus Therapeutics Inc's most recent insider trade came on March 21, 2023 by Michael Raab who sold 4,408 units worth $49.94K . In the last 16 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $186.76M and bought an estimated value of $193.14M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President & CEO, and Daphne Quimi, Chief Financial Officer .
AMICUS THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||